Pulmonx (LUNG)
(Delayed Data from NSDQ)
$1.61 USD
-0.23 (-12.50%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.66 +0.05 (3.11%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
LUNG 1.61 -0.23(-12.50%)
Will LUNG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LUNG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LUNG
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
LUNG: What are Zacks experts saying now?
Zacks Private Portfolio Services
P3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar?
Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last?
Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates
Other News for LUNG
Pulmonx (LUNG) Analyst Ratings Update: Wells Fargo Lowers Price Target | LUNG Stock News
Crude Oil Falls 1%; Meta Earnings Top Views
12 Health Care Stocks Moving In Thursday's Intraday Session
Stifel Lowers Pulmonx (LUNG) Price Target to $5.00, Maintains Buy Rating | LUNG Stock News
Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earnings